Recombinant Pongo abelii Zinc transporter 9 (SLC30A9) refers to a genetically engineered version of the zinc transporter protein found in the Sumatran orangutan (Pongo abelii). This protein is part of the SLC30A family, which plays a crucial role in maintaining zinc homeostasis within cells. Zinc transporters are essential for various cellular functions, including enzyme activity, protein synthesis, and cell signaling. While specific research on the recombinant version of this protein in Pongo abelii is limited, understanding its function and significance can be inferred from studies on similar zinc transporters in other species.
Zinc transporters like SLC30A9 are vital for regulating zinc levels within cells. They ensure that zinc is properly distributed and utilized by various cellular components, such as mitochondria, where it is crucial for energy production and other metabolic processes. In humans and other mammals, mutations in zinc transporters have been linked to various diseases, highlighting their importance in maintaining cellular health .
SLC30A9, specifically, is a mitochondria-resident zinc transporter. Research in humans and model organisms has shown that mutations in this gene can lead to severe developmental and neurological disorders . In Drosophila melanogaster, knockdown of the ZnT9 orthologue results in impaired movement and mitochondrial deformation, underscoring the critical role of this transporter in zinc homeostasis .
Recombinant zinc transporters, including those from Pongo abelii, could potentially be used in biotechnology applications to enhance zinc uptake in organisms grown in environments with limited zinc availability. This could improve crop yields or enhance the nutritional content of food products. Additionally, understanding the mechanisms of zinc transporters could lead to new therapeutic strategies for diseases related to zinc dyshomeostasis .
KEGG: pon:100172026
STRING: 9601.ENSPPYP00000016418
SLC30A9 and SLC39A9 (ZIP9) belong to different families of zinc transporters with distinct functions. SLC30A9 is part of the SLC30 family (also known as ZnT transporters) that primarily function to export zinc from cellular compartments. Specifically, SLC30A9 exports zinc from mitochondria, as evidenced by studies showing that SLC30A9 knockout results in zinc accumulation in mitochondria . In contrast, SLC39A9 (ZIP9) belongs to the SLC39 family that generally imports zinc into cells or cellular compartments. These functional differences are critical when designing experiments investigating zinc homeostasis in cellular systems.
SLC30A9 deficiency leads to multiple mitochondrial defects. Research using SLC30A9 knockout HeLa cells revealed:
Reduced oxygen consumption rates (OCRs), including both ATP-linked OCR and maximal respiration capacity, indicating compromised metabolic activity .
Lower steady-state NADH/NAD⁺ ratio compared to control cells, consistent with reduced oxidative phosphorylation .
Decreased abundance of specific respiratory chain components, particularly complex I subunit NDUFB8 and complex III subunit UQCRC2, while complex V-ATP5A levels remained normal .
Direct measurement of complex I activity showed reduced function in SLC30A9⁻/⁻ cells .
Abnormally reductive conditions in mitochondria, evidenced by an increased GSH/GSSG ratio, suggesting defective oxidative processes .
SLC30A9 likely functions as a Zn²⁺/H⁺ exchanger, sharing extensive sequence homology with the bacterial Zn²⁺/H⁺ exchanger YiiP . Structure-function studies support this hypothesis:
Sequence homology analysis and comparison with known protein structures of YiiP, ZnT2, and ZnT8 identified putative Zn²⁺/H⁺ binding sites .
Site-directed mutagenesis experiments demonstrated that the H198A mutation partially rescued the mitochondrial swelling phenotype in slc-30a9 mutants, while the D323A mutation showed no rescue activity .
These results suggest that SLC30A9 utilizes the mitochondrial proton gradient to transport Zn²⁺, functioning as a proton-dependent antiporter .
This mechanism explains how SLC30A9 can export zinc from mitochondria against its concentration gradient by coupling zinc transport to the proton motive force across the mitochondrial membrane.
SLC30A9 plays a critical role in sperm function:
In C. elegans, SLC30A9 is required for sperm activation by weak bases like TEA/ammonium chloride, a process involving zinc extrusion from mitochondria .
Experimental evidence shows that zinc chelators and mitochondrial membrane potential blockers inhibit sperm activation, supporting the model that SLC30A9 mediates proton gradient-dependent zinc mobilization from mitochondria during this process .
SLC30A9 is also required for normal brood size in vivo, suggesting a physiological role in sperm activation and fertility .
This function appears to be conserved across species, as zinc mobilization is important for sperm function in multiple organisms, including sea urchins and mammals .
These findings highlight the importance of dynamic zinc regulation via SLC30A9 not just for steady-state homeostasis but also for signal transduction during reproductive processes.
The search results provide a detailed protocol for SLC30A9 knockout using CRISPR-Cas9:
sgRNA Design: Select an optimal sgRNA sequence using a CRISPR design tool. For SLC30A9, the sequence 5′-CCCTGTAGTCATCCATATATTGG-3′ targeting exon 2 was effectively used .
Vector Construction: Express the sgRNA in a suitable vector, such as AAV-U6-sgRNA-CMV-mCherry .
Cell Line Expression: Introduce the sgRNA expression vector into cells already stably expressing Cas9 protein .
Clone Selection: Sort cells expressing the marker (e.g., mCherry) using fluorescence-activated cell sorting (FACS). For the reported study, a BD FACSAria TMIIIu was used .
Clone Expansion: Select and expand single clones for biological assays .
Verification: Confirm knockout using sequence analysis of the targeted gene region. For SLC30A9, the following primers were used: forward, 5′-AAAATCGGTGACAGT-ATGAATGAAT-3′ and reverse, 5′-TAATAAAACACAAACCTCTGGGAAG-3′ .
This protocol can be adapted for generating knockout models in different cell lines to study the function of SLC30A9 in various cellular contexts.
Several complementary techniques for evaluating mitochondrial function in the context of zinc transporter research include:
Oxygen Consumption Rate (OCR) Measurement:
Use a metabolic analyzer to measure OCR
Treat cells sequentially with:
Oligomycin (to inhibit ATP synthase)
FCCP (carbonyl cyanide 4-(trifluoromethoxy) phenylhydrazone, a mitochondrial uncoupler)
Rotenone and antimycin A (to inhibit electron transport chain)
Calculate ATP-linked OCR and maximal respiration capacity from the resulting data
NADH/NAD⁺ Measurement:
Respiratory Complex Abundance Assessment:
Complex I Activity Measurement:
Redox State Evaluation:
Express mitochondria-targeted Grx1-roGFP2 to measure the GSH/GSSG ratio
Validate the sensor using dithiothreitol (to increase GSH/GSSG ratio) and diamide (to decrease GSH/GSSG ratio)
Compare the GSH/GSSG ratio between experimental and control groups
Alternatively, extract mitochondria and measure the GSH/GSSG ratio using a dedicated assay kit
These methods provide complementary data on different aspects of mitochondrial function and can reveal how zinc transporters like SLC30A9 impact energy metabolism and mitochondrial physiology.
Based on the product information for recombinant Pongo abelii ZIP9 (SLC39A9), the following handling procedures are recommended:
Storage Conditions:
Reconstitution Protocol:
Storage Buffer:
Quality Control:
These guidelines ensure optimal protein stability and activity, which is critical for experimental reliability when working with recombinant zinc transporters in research settings.
For studying zinc transporters like SLC30A9 and SLC39A9, several techniques can be employed to visualize zinc distribution:
Genetically Encoded Zinc Sensors:
Zinc-Specific Fluorescent Probes:
Ultrastructural Analysis:
Zinc Mobilization Assays:
Treatment with weak bases like TEA/ammonium chloride can be used to induce zinc mobilization
Combined with zinc sensors, this approach can reveal the dynamics of zinc transport
Zinc chelators and mitochondrial membrane potential blockers can be used as controls to confirm the specificity of the observed effects
These methods provide complementary information about zinc distribution and dynamics, which is essential for understanding the function of zinc transporters in different cellular contexts.
When interpreting phenotypes of zinc transporter knockouts like SLC30A9, researchers should consider several potential confounding factors:
Compensatory Mechanisms: Other zinc transporters may partially compensate for the loss of the targeted transporter, potentially masking the full phenotype. For example, other members of the SLC30 family might partially compensate for SLC30A9 deficiency, requiring careful examination of multiple zinc transport pathways.
Secondary Effects: The primary defect in zinc homeostasis may lead to numerous secondary effects that are not directly caused by the transporter itself. In SLC30A9 knockout cells, mitochondrial swelling and cristae disruption could lead to multiple downstream consequences that are indirect effects of the primary zinc imbalance .
Developmental vs. Acute Effects: In model organisms, germline knockouts may have developmental consequences that differ from acute knockdowns in adult tissues. This consideration is particularly important when studying zinc transporters involved in fertility and development .
Tissue-Specific Functions: Zinc transporters often have tissue-specific roles. The research shows that SLC30A9 is important in both sperm cells and neurons, with potentially different functional consequences in each tissue type .
Species-Specific Differences: While the zinc transport function appears conserved across species, the specific physiological roles may vary. The researchers demonstrated SLC30A9 function in both C. elegans and human cells, indicating conservation but potentially with species-specific nuances .
Careful experimental design with appropriate controls and multiple complementary approaches can help address these potential pitfalls.
To distinguish direct from indirect effects of zinc transporter disruption:
Rescue Experiments: Reintroducing the wild-type transporter should reverse direct effects. The research demonstrated that introducing the H198A variant of SLC30A9 partially rescued the mitochondrial swelling phenotype, while the D323A variant showed no rescue activity, suggesting direct mechanistic insights into the protein's function .
Zinc Supplementation or Chelation: Manipulating zinc levels can help determine whether phenotypes are directly related to zinc imbalance. The research used zinc chelators to investigate the role of zinc in sperm activation, confirming the direct link between zinc mobilization and cellular function .
Temporal Analysis: Monitoring the sequence of events following transporter disruption can help establish cause-effect relationships. Early changes are more likely to be direct effects, while later changes might represent secondary consequences.
Structure-Function Studies: Targeted mutations of specific functional domains can link molecular functions to cellular phenotypes. The researchers introduced specific mutations (D323A and H198A) to disrupt putative Zn²⁺/H⁺ binding sites, providing mechanistic insights into how SLC30A9 functions .
Combined Genetic Approaches: Creating double knockouts with other zinc homeostasis genes can reveal functional relationships and compensatory mechanisms. This approach can help determine whether observed phenotypes are specifically due to the targeted transporter or represent broader disruptions in zinc homeostasis.
By integrating these approaches, researchers can build a more comprehensive and accurate understanding of zinc transporter function in cellular physiology.
Several promising research directions emerge from the current understanding of zinc transporters like SLC30A9:
Neurological Disorders: The research suggests that mitochondrial swelling and transport defects in neurons might underlie one form of cerebrorenal syndrome . Further investigation into the role of SLC30A9 in neuronal function and neurodegenerative diseases represents a valuable research direction.
Fertility Research: Given the critical role of SLC30A9 in sperm activation and zinc mobilization, further studies on zinc transporter functions in reproductive biology could yield insights into fertility disorders and potential therapeutic approaches .
Mitochondrial Diseases: The profound effects of SLC30A9 deficiency on mitochondrial morphology and function suggest that zinc transporters might play underappreciated roles in mitochondrial diseases. Investigating zinc dysregulation in established mitochondrial disease models could reveal new therapeutic targets .
Metabolic Disorders: The observed defects in oxidative phosphorylation and cellular metabolism in SLC30A9-deficient cells indicate potential connections to metabolic disorders. Exploring these links in relevant disease models could provide new perspectives on metabolic regulation .
Comparative Physiological Studies: Extending the investigation of zinc transporters across different species and tissues could reveal evolutionary conservation and specialization of zinc transport mechanisms, providing broader insights into zinc homeostasis regulation .
These research directions hold promise for both basic science advances and potential therapeutic applications in various disease contexts.
Structural biology approaches offer significant potential for advancing zinc transporter research:
Detailed Structural Analysis: Building on the sequence homology with bacterial Zn²⁺/H⁺ exchanger YiiP, more detailed structural studies of SLC30A9 and SLC39A9 could reveal critical insights into transport mechanisms . Techniques such as cryo-electron microscopy or X-ray crystallography could elucidate the three-dimensional structure of these transporters.
Structure-Guided Mutagenesis: The partial rescue of the SLC30A9 phenotype by the H198A variant, but not the D323A variant, points to specific structural elements important for function . Systematic structure-guided mutagenesis could map functional domains and residues critical for zinc binding, transport, and regulation.
Conformational Changes During Transport: Understanding how zinc transporters change conformation during the transport cycle would provide mechanistic insights. Techniques like single-molecule FRET could capture these dynamic structural changes.
Protein-Protein Interaction Mapping: Identifying binding partners of zinc transporters through techniques like co-immunoprecipitation followed by mass spectrometry could reveal regulatory mechanisms and functional networks.
Comparative Structural Analysis: Comparing the structures of different zinc transporters (e.g., SLC30A9 vs. SLC39A9) could highlight conserved features essential for zinc transport as well as unique elements that determine substrate specificity and directionality.
These structural approaches would complement functional studies and provide a more comprehensive understanding of zinc transporter biology at the molecular level.